The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesMedicare Part D and quality of prescription medication use in older adultsThe impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utilityAssessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patientsSocioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part DDementia and out-of-pocket spending on health care services.Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.Medicare Part D--lessons learned and guidance for health-care reform.Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic reviewGastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over timeThe impact of Medicare Part D on medication treatment of hypertension.Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007The impact of Medicare Part D on hospitalization ratesDrug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expendituresClopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stentBeneficiaries with cardiovascular disease and thePart D coverage gap.Reconsideration of key articles regarding medication-related problems in older adults from 2011.Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees.Medicare Part D's effect on the under- and overuse of medications: a systematic review.Association between the Part D coverage gap and adverse health outcomes.Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.Time trends in medication use and expenditures in older patients with rheumatoid arthritisThe effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failurePersistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS studyCost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.Effects of Medicare Part D coverage gap on medication adherence.Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D.Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme.Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence.Medicare Part D Implementation and Associated Health Impact Among Older Adults in the United States.The Effects of Medicare Part D on Health Outcomes of Newly Covered Medicare Beneficiaries.Impact of Medicare Part D on coverage, access, and disparities among new jersey seniors.How Did Medicare Part D Affect Racial and Ethnic Disparities in Drug Coverage?The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part D.
P2860
Q24188009-3400741D-B8B6-4540-AFE4-B0DDAD05F10EQ27023843-EE9B16DA-A6DC-44CA-BDA9-95188903E3D4Q28238484-E34087F2-6AB6-4BA9-AE69-B135E85FB542Q31060705-2E65EA88-4984-4D31-95CC-45A9CDECA470Q33511568-CD1C28A7-15C0-4252-8CE9-2C74A0CFA599Q33563718-E198FAEB-B046-42E9-89DB-B14ABBED8A0BQ33603905-3485732F-3F61-4F87-A627-939CF4ED7ABBQ33611387-43434E5B-EEF8-4561-90E1-E949282DF722Q33611440-BB899FFD-5DA9-4945-90BC-43F8687E62B4Q33865820-1AF640E8-E210-4FBB-BF3F-06D813D09467Q34158480-B9F6A4AA-C9DD-4C50-8C18-D28344B16B38Q34389027-F0D64A85-6371-4C97-9CC4-72D71C9EF669Q34554697-55259572-DA8F-499E-BB97-CD900B2D84BBQ35073728-520728A6-F550-4C88-802F-CE0DE25942CAQ35151469-4150160F-2DEF-46AB-98E9-78492B194A0EQ35190976-12C7BD2A-12B8-4EE0-9E09-6FEA9C8FAEF5Q35235565-DC1F1BCB-A366-44EB-B915-453D67D161E9Q35680854-6E81D377-9C18-4571-B0AE-2DE4C2E4C353Q35992856-C724B39E-CE7F-44D7-AEC5-C0F30A9753E9Q36043785-6EA58073-E3AD-4BA4-AA9F-CE61A54150F5Q36079132-26F8A884-BABC-4383-8848-4B9ABF660AE1Q36087210-4C658E1E-C9E6-49A8-A65D-9F9182161643Q36105740-6D1F8EA0-914D-4A8A-98EE-295E206F297DQ36164651-3126EDA2-2802-4109-9356-2C1C81C6E730Q36165497-BC8E7291-2CE7-479F-96F9-836A494BB368Q36204927-9E3512A9-E1E9-4723-A1BA-2ECE20B695EBQ36318602-F41DB0E4-3E4B-47DB-AAF0-D93F40E999DEQ36729617-1F85472C-4882-4FBE-A308-9897AB20B4A7Q36927439-B3683800-AF33-4E80-A2AC-C56C9F31C065Q37013366-A74D9C46-F6C4-4F6B-B55F-03ED764AD0CAQ37241199-8DE8AFC9-B7AA-43C0-8513-D3F9BA30CE88Q37867097-79EDC2E6-44B8-4DD1-B7EE-8EC15D335228Q38977081-DBDF8930-F9B2-48A1-8A1B-7075EA50BFD2Q39229645-448709CF-2D31-4E9C-AF64-8055AB52EC1DQ39786846-8E54B6C3-B6EE-478E-AA36-2A0570C6540BQ41641634-67FA5CA9-18A9-43E0-B176-7B6CE317D098Q41657936-66AD53FD-DDAB-4267-8117-BD89F46F25FFQ43722424-DBD67872-28E8-4234-AE1B-7ED2D85A4B36Q46092180-7F666E64-0724-4597-B075-BC72234806FBQ50797270-43622F82-124B-4E38-853A-0CB3CC23406D
P2860
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of Medicare Part D ...... rs without prior drug benefits
@en
The effect of Medicare Part D ...... s without prior drug benefits.
@nl
type
label
The effect of Medicare Part D ...... rs without prior drug benefits
@en
The effect of Medicare Part D ...... s without prior drug benefits.
@nl
prefLabel
The effect of Medicare Part D ...... rs without prior drug benefits
@en
The effect of Medicare Part D ...... s without prior drug benefits.
@nl
P2093
P2860
P1433
P1476
The effect of Medicare Part D ...... rs without prior drug benefits
@en
P2093
Alex Pedan
Amanda R Patrick
Laleh Varasteh
Raisa Levin
Sebastian Schneeweiss
William H Shrank
P2860
P304
P356
10.1377/HLTHAFF.28.2.W305
P407
P577
2009-02-03T00:00:00Z